Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $18,000.00 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 20,000 shares of the firm’s stock in a transaction dated Tuesday, May 21st. The stock was bought at an average price of $0.90 per share, with a total value of $18,000.00. Following the acquisition, the chief executive officer now directly owns 14,442,749 shares in the company, valued at $12,998,474.10. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Retractable Technologies Price Performance

Retractable Technologies stock traded up $0.01 during midday trading on Friday, reaching $0.94. 56,182 shares of the company’s stock were exchanged, compared to its average volume of 111,206. Retractable Technologies, Inc. has a 52 week low of $0.87 and a 52 week high of $1.34. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01. The stock’s 50-day simple moving average is $1.09 and its 200 day simple moving average is $1.14.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $7.60 million during the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on Retractable Technologies in a report on Sunday, May 19th. They set a “hold” rating for the company.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.